The consumer demand for injectable medications to control diabetes and aid weight loss isn't slowing down. And that's going ...
Could popular anti-obesity medications have an impact on alcohol misuse? KYW medical editor Dr. Brian McDonough has more from ...
The FDA put both peptides on its shortage list in 2022. Semaglutide is still on that list, while the FDA lifted its shortage ...
A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...
Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.
Two new studies identified additional benefits of medications like semaglutide—the active ingredient in Novo Nordisk's ...
Reports of pulmonary aspiration and difficulties in diagnosing gastrointestinal complications in the perioperative period have highlighted the need for clear clinical guidance to manage these patients ...
As drugs like Ozempic and Wegovy keep flying off the shelves, more and more people are taking the drug into their own hands ...
Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.
The use of GLP-1s is linked to improved inflammatory bowel disease outcomes in patients with concomitant inflammatory bowel ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) reduce the risk for clinically important kidney and cardiovascula ...
A study finds that anti-obesity medications may help reduce alcohol consumption, with nearly half of participants in weight ...